Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2

Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy

NCT03359642 ·Status: COMPLETED ·Phase: NA

Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine

NCT05584735 ·Status: COMPLETED

Covid-19 Vaccine Responses in Patients With Inflammatory Bowel Diseases

NCT05067959 ·Status: UNKNOWN

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease

NCT02904590 ·Status: COMPLETED

A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice

NCT03532932 ·Status: COMPLETED

A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)

NCT03488030 ·Status: COMPLETED

A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis

NCT05377580 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

NCT01659138 ·Status: TERMINATED ·Phase: PHASE2

Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease

NCT00561548 ·Status: TERMINATED ·Phase: NA

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

NCT01022749 ·Status: COMPLETED ·Phase: PHASE3

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

NCT07242248 ·Status: RECRUITING

Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD

NCT02255227 ·Status: TERMINATED ·Phase: PHASE2

GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )

NCT02994836 ·Status: COMPLETED ·Phase: PHASE4

Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil

NCT02822235 ·Status: COMPLETED

Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases

NCT02508012 ·Status: COMPLETED ·Phase: NA

Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients.

NCT03889808 ·Status: UNKNOWN

A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease

NCT02505568 ·Status: COMPLETED ·Phase: PHASE3

Can we Rely on HLA to Predict Resistance to Biological Therapy in IBD Patients

NCT05040854 ·Status: UNKNOWN

Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease

NCT03885713 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

NCT04769258 ·Status: UNKNOWN

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

NCT05817942 ·Status: ACTIVE_NOT_RECRUITING

Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

NCT00829595 ·Status: COMPLETED ·Phase: NA

Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis

NCT03018925 ·Status: COMPLETED

Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic

NCT04344249 ·Status: COMPLETED

Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

NCT00542776 ·Status: COMPLETED